Pfizer CEO: Metsera deal gives us ‘one of the most exciting, advanced portfolios’ in obesity drugsNovember 10, 2025
Share Facebook Twitter LinkedIn Pinterest Email Barbara Reinhard, Voya Investment Management CIO of multi-asset strategies and solutions, joins ‘Squawk Box’ to discuss the latest market trends, state of the economy, year-end outlook, where investors can find opportunity right now, and more.